Trade Summary

3 days ago, BRYNJELSEN SEAN, serving as President & CEO at Eton Pharmaceuticals, Inc. (ETON), sold 100,000 shares at $60.88 per share, for a total transaction value of $6,087,772.96. Following this transaction, BRYNJELSEN SEAN now holds 961,194 shares of ETON.

This sale represents a 9.42% decrease in BRYNJELSEN SEAN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 6:26 PM ET, 1 day after the trade was made.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.